Pharmaceutical Terminology in PT, ES and FR: A Practical Guide

Pharmaceutical translation is not a task for strong linguists alone. It requires precise command of domain-specific terminology across each regulatory context, because a loosely translated term in a clinical trial protocol or a drug label can derail a regulatory submission or create clinical risk. This guide covers the essential pharmaceutical terms in Portuguese (PT), Spanish (ES) and French (FR) for the most common translation scenarios in this sector.

Why pharmaceutical terminology diverges across closely related languages

Portuguese, Spanish and French share a Latin root, which creates a false sense of terminological transparency. Direct equivalents fail more often than expected. "Comprimido" in Portuguese maps neatly to "comprimido" in Spanish, but becomes "comprimé" in French. That is the easy case. "Bula" in Portuguese, the patient information leaflet, is "prospecto" in Spanish and "notice" in French. Using the wrong term in a regulatory dossier submitted to INFARMED, AEMPS or ANSM creates immediate ambiguity.

Each national regulatory authority has its own terminological preferences. The EMA publishes glossaries in all EU official languages, and the approved terms in those documents do not always match usage in academic or industrial contexts. A pharmaceutical translator needs to know both registers.

Core glossary: clinical and regulatory terms

The table below covers the most frequent terms in marketing authorisation documentation, clinical trials and labelling.

Portuguese (PT)	Spanish (ES)	French (FR)
Autorização de introdução no mercado	Autorización de comercialización	Autorisation de mise sur le marché
Bula	Prospecto	Notice
Comprimido revestido	Comprimido recubierto	Comprimé pelliculé
Dose diária definida	Dosis diaria definida	Dose journalière définie
Efeito adverso	Efecto adverso	Effet indésirable
Ensaio clínico	Ensayo clínico	Essai clinique
Excipiente	Excipiente	Excipient
Farmacocinética	Farmacocinética	Pharmacocinétique
Farmacovigilância	Farmacovigilancia	Pharmacovigilance
Forma farmacêutica	Forma farmacéutica	Forme pharmaceutique
Indicação terapêutica	Indicación terapéutica	Indication thérapeutique
Posologia	Posología	Posologie
Princípio activo	Principio activo	Principe actif
Reacção adversa medicamentosa	Reacción adversa al medicamento	Réaction indésirable médicamenteuse
Resumo das características do medicamento	Ficha técnica	Résumé des caractéristiques du produit
Substância activa	Sustancia activa	Substance active
Via de administração	Vía de administración	Voie d'administration

One critical point: the central technical document for any approved medicine is called the Resumo das Características do Medicamento (RCM) in Portugal, the Ficha Técnica in Spain and the Résumé des Caractéristiques du Produit (RCP) in France. These documents are functionally equivalent but carry different designations. Confusing the abbreviations in a regulatory dossier creates problems that take time to resolve.

Process and quality terminology

Manufacturing, validation and quality control documentation carries its own terminological layer. The following terms appear frequently in GMP and quality contexts:

Portuguese (PT)	Spanish (ES)	French (FR)
Boas Práticas de Fabrico	Buenas Prácticas de Fabricación	Bonnes Pratiques de Fabrication
Certificado de análise	Certificado de análisis	Certificat d'analyse
Contaminação cruzada	Contaminación cruzada	Contamination croisée
Desvio de qualidade	Desviación de calidad	Déviation qualité
Especificação	Especificación	Spécification
Lote	Lote	Lot
Prazo de validade	Fecha de caducidad	Date de péremption
Produto acabado	Producto terminado	Produit fini
Rastreabilidade	Trazabilidad	Traçabilité
Validação de processo	Validación de proceso	Validation de procédé

Drug labelling is one area where terminology errors have direct consequences for both patient safety and marketing authorisation. The requirements for drug labelling translation follow specific regulatory frameworks that differ across these three markets.

False cognates and common errors

The proximity of these three languages produces specific translation errors that would not arise in more distant language pairs. Some examples worth noting:

• "Intoxicación" (ES) and "intoxicação" (PT) both refer to poisoning or acute intoxication. The French cognate "intoxication" is used less frequently in clinical contexts, where "empoisonnement" or "surdosage" may be preferred depending on the situation.
• "Sensibilidad" (ES) and "sensibilidade" (PT) can both refer to clinical sensitivity in a diagnostic sense. In French, the clinical context uses "sensibilité", while allergic contexts prefer "hypersensibilité".
• "Adherencia" (ES) versus "adesão" (PT) versus "observance" (FR): all three refer to therapeutic compliance by the patient, but the French term is structurally different from the other two. A translator working from Spanish into French who applies a literal strategy will produce a term that reads oddly in French regulatory documents.
• "Posología" (ES) and "posologie" (FR) map directly to "posologia" (PT), but their semantic scope can differ subtly in EMA regulatory documents, depending on how the source text frames dosing instructions.

These deviations are invisible to reviewers without specific training in pharmacy or health sciences. A generalist translator with strong linguistic skills will not catch them reliably.

Ensuring terminological consistency in multilingual projects

In projects covering all three languages simultaneously, consistency requires both the right tools and a structured process. The key steps are:

• Validated project glossary: created before translation begins, with terms approved by the client's regulatory team.
• Language-specific translation memories: ensure that equivalent segments always receive the same terminological solution across versions.
• Subject-matter expert review: linguistic review does not substitute review by a pharmacist or health sciences professional.
• Document version control: in pharmaceutical contexts, the source document version determines the translation versions. Traceability is mandatory in regulatory submissions.

In clinical trials, where documentation spans informed consents, protocols and safety reports, consistency across language versions is audited by the relevant authorities. The translation of clinical trial protocols for regulatory submission follows requirements that go well beyond linguistic equivalence.

M21Global: pharmaceutical translation with controlled terminology

M21Global has extensive experience in pharmaceutical translation for Portuguese, Spanish and French markets. The pharmaceutical translation service includes project-specific glossaries, dedicated translation memories and review by translators with health sciences backgrounds. For high-impact regulatory documentation, the Estratégica workflow provides independent review and quality control audited to ISO 17100. Contact the team to discuss the specific requirements of a project and receive a proposal matched to the documentation type.

Related Services

Request a free medical translation quote

• Request a free medical translation quote
• Medical Device Documentation Translation Mdr Compliance
• Translating Clinical Trial Protocols Regulatory Submission
• Drug Labeling Translation

Frequently Asked Questions